Pharmacological and biochemical aspects of hyperkinetic disorders
- 31 December 1979
- journal article
- review article
- Published by Elsevier in Neuropharmacology
- Vol. 18 (12), 923-929
- https://doi.org/10.1016/0028-3908(79)90156-4
Abstract
No abstract availableThis publication has 51 references indexed in Scilit:
- A dopaminergic basis for the effects of amphetamine on a mouse “preadolescent hyperkinetic” modelLife Sciences, 1977
- CSF monoamine metabolites in children with minimal brain dysfunction: Evidence for alteration of brain dopamineThe Journal of Pediatrics, 1977
- Early asymptomatic lead exposure and development at school ageThe Journal of Pediatrics, 1975
- Possible role of 5-hydroxytryptamine in minimal brain dysfunctionLife Sciences, 1975
- Some speculations concerning a possible biochemical basis of minimal brain dysfunctionLife Sciences, 1974
- A familial factor in minimal brain dysfunctionBehavior Genetics, 1973
- Does asymptomatic lead exposure in children have latent sequelae?The Journal of Pediatrics, 1972
- Serotonin concentrations in whole blood of hyperactive childrenThe Journal of Pediatrics, 1971
- Development of social fear after amygdalectomy in infant rhesus monkeysPhysiology & Behavior, 1969
- Postencephalitic, ordinary and extraordinary childrenThe Journal of Pediatrics, 1932